Depomed to Present at Healthcare Conferences in February

NEWARK, Calif., Feb. 03, 2016 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will be presenting at the following healthcare conferences during the month of February.

LEERINK Partners 5th Annual Global Healthcare Conference

Date: Wednesday, February 10, 2016 Time: 11:55 a.m. EST Location: New York, New York

2016 RBC Capital Markets’ Global Healthcare Conference

Date: Wednesday, February 24, 2016 Time: 11:00 a.m. EST Location: New York, New York

These presentations will be webcast and can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A recording of the webcasts will be archived for 30 days.

About Depomed

Depomed is a leading specialty pharmaceutical company focused on enhancing the lives of the patients, families, physicians, providers and payors we serve through commercializing innovative products for pain and neurology related disorders. Depomed markets six medicines with areas of focus that include mild to severe acute pain, moderate to severe chronic pain, neuropathic pain, migraine and breakthrough cancer pain. Depomed is headquartered in Newark, California. To learn more about Depomed, visit www.depomed.com

Investor Contact:

Christopher Keenan
VP, Investor Relations and Corporate Communications
510-744-8000
[email protected]

You May Also Be Interested In

• RBC Capital Resumes BorgWarner (BWA) at Outperform
• Michelin: Disclosure of trading in own shares - September 3rd, 2026
• NSW's Fourth-Largest City Makes Its Move: Investing Platform Spotlights Wollongong's Health Precinct Plan and 20,500-Job Target